---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-077296"
form_type: "8-K"
ticker: "SILO"
cik: "0001514183"
company_name: "Silo Pharma, Inc."
filed_at: "2026-07-10T22:29:27+00:00"
generated_at: "2026-07-13T10:05:38.754262+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Silo Pharma raises $4M in private placement; warrants could add $7.7M

## Summary
- Issued 619,965 shares (or pre-funded warrants) at $6.452/share plus Series A-3 and A-4 warrants.
- Warrants exercisable at $6.21/share; Series A-3 expire 5 years, Series A-4 expire 18 months after registration.
- Net proceeds expected ~$3.5M after fees; H.C. Wainwright acted as placement agent.
- Proceeds to be used for working capital and general corporate purposes.
- Potential additional $7.7M if all warrants exercised for cash; no assurance of exercise.

## SEC filing metadata
- accession: 0001213900-26-077296
- form_type: 8-K
- ticker: SILO
- cik: 0001514183
- company_name: Silo Pharma, Inc.
- filed_at: 2026-07-10T22:29:27+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1514183/000121390026077296/0001213900-26-077296-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1514183/000121390026077296/ea0297602-8k_silo.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-077296
- JSON: https://secwatch.observer/filing/0001213900-26-077296.json
- Plain text: https://secwatch.observer/filing/0001213900-26-077296.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.